Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
3.275
-0.225
(-6.43%)
Streaming Delayed Price
Updated: 10:44 AM EDT, Aug 24, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Recursion Pharmaceuticals Q2 Earnings Call Highlights ↗
August 05, 2026
Recursion to Participate in Upcoming Investor Conferences
August 04, 2026
3 Stocks With the Most Upside by the End of 2026 ↗
July 30, 2026
2 Beaten-Down Stocks That Still Aren't Worth Buying ↗
July 11, 2026
A Deep Dive Into NVIDIA’s Latest Portfolio Moves ↗
May 19, 2026
Frequently Asked QuestionsIs Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.275
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 08/24/26 10:44 AM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 551.59M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 552M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
